ADCI.CA Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: December 09, 2025
Report Source: 2026 1st Quarter Report
Arab Drug Company for Pharmaceuticals and Chemical Industries SAE. Stock Analysis ADCI.CA
Arab Pharmaceuticals engages in the manufacture, packaging, distribution and trade of drugs, pharmaceuticals, and chemicals. The company is headquartered in Cairo, Cairo. The firm focuses on the manufacture, packaging and distribution of pharmaceutical products and chemical solutions for human and veterinary use. The firm's product categories include tablets, aerosols and sprays. The major shareholder of the Company is Holding Company for Pharmaceuticals (HoldiPharma) with a stake of 60%.
Read More Arab Drug Company for Pharmaceuticals and Chemical Industries SAE (ADCI.CA) Chart
Key Statistics of Arab Drug Company for Pharmaceuticals and Chemical Industries SAE (ADCI.CA)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
EGP218.51Volume
22.01KP/E Ratio (TTM)
11.5152 Week Range
Market Cap
2.32BAvg. Volume
51.64KDividend Yield
3.15%Financial Metrics & Statements of Arab Drug Company for Pharmaceuticals and Chemical Industries SAE (ADCI.CA)
FAQ's for Arab Drug Company for Pharmaceuticals and Chemical Industries SAE (ADCI.CA)
- According to Musaffa’s Shariah screening methodology, Arab Drug Company for Pharmaceuticals and Chemical Industries SAE (ADCI.CA) is currently classified as NOT HALAL as of December 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.